About Our Program

As a research center embedded within Kaiser Permanente’s large and dynamic health care system, our investigators have a unique opportunity to apply scientific expertise to real-world clinical problems, translate findings into practice, and share what we learn with the broader community.

Featured Scientist

Dr. Corinna Koebnick headshot
Corinna Koebnick, PhD, MSc
Research Scientist II
Division of Behavioral Resarch

Dr. Corinna Koebnick is a nutrition scientist and obesity researcher whose work focuses on the prevention and treatment of obesity in children, adolescents, and young adults. Her research examines critical issues such as the health consequences of obesity. She also studies ways to optimize the health services provided to individuals with obesity.

Dr. Koebnick pursues a strong interest in molecular epidemiology. She is currently investigating the interactions between diet and adipokines. ...

Featured Video

Advancing treatments through clinical trials

Over the years, clinical trials have led to amazing advances in treatment—even cures—for devastating illnesses. William Towner, MD, FACP, FIDSA, regional physician director for clinical trials, describes how trials at Kaiser Permanente contribute to the development of more effective and safer treatments for diseases such as HIV, hepatitis C, cancer, and more. (2:15)


Featured Image of News Story Titled: Five questions for … Dr. Michael Aragones

Five questions for … Dr. Michael Aragones

Kaiser Permanente Southern California has 2 Regional Reference Laboratories, which make up a sophisticated clinical laboratory management system that interfaces with medical centers and medical offices throughout the region. Michael Aragones, MD, is a Research & Evaluation research lab project manager at the Sherman Way and Chino Hills regional laboratories, which share responsibility for testing ...

Increasing vaccine equity in Southern California

In addition to bringing isolation and illness to the world, the COVID-19 pandemic spotlighted the health disparities between Southern California communities. Getting COVID-19 vaccines to the neighborhoods where they were most needed was one of the greatest challenges health care providers experienced during the pandemic. At Kaiser Permanente in Southern California, people rallied to address ...

Atrial fibrillation may increase risk for dementia

People who have been diagnosed with atrial fibrillation are known to have an increased risk of developing other heart problems. A new Kaiser Permanente study suggests they may also be at increased risk for dementia. The researchers found that people with atrial fibrillation, the most common type of irregular heartbeat, had a 13% greater risk ...

Paxlovid associated with lower risk of hospital admission

A Kaiser Permanente study confirms the benefit of nirmatrelvir-ritonavir, also known as Paxlovid, as an early-stage treatment to prevent hospitalization for people with mild to moderate COVID-19, regardless of prior immunity or age. The study was published March 15, 2023, in The Lancet Infectious Diseases. “Among Kaiser Permanente members in Southern California who tested positive ...

Extra pounds put kids at higher risk for hypertension

A study of more than 800,000 young people between the ages of 3 and 17 showed that youth at the upper range of average  weight had a 26% higher risk of developing hypertension than those closer to what is considered average weight. The study was published March 14, 2023, in JAMA Network Open. “Hypertension during ...


Featured Division

Clinical Trials Research

Our physician investigators conduct clinical trials in communities across Southern California, from Bakersfield to San Diego.

The Division of Clinical Trials Research advances medical innovation by supporting evaluation of new drugs, therapies, and devices to prevent and treat health problems. Our physician investigators work with cooperative groups and industry sponsors to conduct clinical trials for investigational drugs, biologics, and devices. In addition, the division develops pragmatic trials that help answer questions about care delivery.

The region has clinical trials programs in oncology (adult, gynecologic, pediatric, and surgical/radiation oncology), urology, gynecology, neurology, dermatology, metabolic diseases, nephrology, ophthalmology, infectious disease, cardiology, hepatology, vascular surgery, and rheumatology. Clinical trials staff support trials at medical centers and medical office buildings throughout the Kaiser Permanente Southern California Region.